Aphios Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Aphios Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					            Aphios Corporation - Pharmaceuticals & Healthcare - Deals and Alliances
                                           Profile
       Reference Code: GDPH26177D                                                                                                            Publication Date: JUN 2013

      Company Overview                                                                                        Key Facts
      Aphios Corporation (Aphios) is a pharmaceutical company. The company develops
                                                                                                              Aphios Corporation, Pharmaceuticals & Healthcare,
      technology platforms and enhanced therapeutics for the treatment of certain
                                                                                                              Key Facts
      infectious diseases, cancers and CNS disorders. Its product pipeline includes Zindol,
      an enhanced ginger product; APH-0703, a potent protein kinase C activator; APH-                          Web Address                        www.aphios.com
      0812, a combination therapy consisting of PKC modulators with or without HDAC
                                                                                                               Revenue (US$ million)                           NA
      inhibitors; AMPI-109, a nontoxic Vitamin D3 derivative for hormone refractory
      prostate cancer; APH-0911, a nanotechnology formulation; and others. The                                 Number of Employees                             NA
      company offers biotechnology and nanotechnology drug delivery platforms.                                 GlobalData

      Financial Deals Landscape
        Aphios Corporation, Pharmaceuticals & Healthcare, Deals by                        Aphios Corporation, Pharmaceuticals & Healthcare, Deals
        Type, 2007 to YTD 2013                                                            By Year, 2007 to YTD 2013


                                                                                                                                  3
                                                                                                          3



                                                                                           No. of Deals
                                                                                                          2

                                                                                                                                                  1
                                                                                                          1

                                                                                                                 0       0               0                0        0
                                                                                                          0
                                                                                                               2007     2008     2009   2010   2011     2012   YTD
                                                                                                                                                               2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Aphios Corporation, Pharmaceuticals & Healthcare, Deals                          Aphios Corporation, Pharmaceuticals & Healthcare, Deals
         By Region, 2007 to YTD 2013                                                      By Therapy Area, 2007 to YTD 2013

                         5
                               4
                                                                                                                         2
          No. of Deals




                         4
                                                                                                          2
                                                                                           No. of Deals




                         3
                         2
                                          1                                                                                              1                1
                         1                                                                                1
                                                      0            0
                         0
                              North    Europe      Middle       South
                             America              East and       and
                                                   Africa      Central                                    0
                                                               America                                                Oncology        Immunolog       Infectious
                                                                                                                                          y            Disease


         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          from 2006 onwards, GlobalData




Aphios Corporation - Pharmaceuticals & Healthcare - Deals and                                                                                  Reference Code: GDPH26177D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................... 4
       Aphios Corporation, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................................... 5
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................... 6
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ..................................................... 7
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ................................................................ 8
       Aphios Corporation, Pharmaceuticals & Healthcare, Deal Details ..................................................................................................... 9
          Partnerships.................................................................................................................................................................................... 9
             Aphios Enters Into An Agreement With SAIC-Frederick.............................................................................................................. 9
             Aphios Enters Into Co-Development Agreement With National Cancer Institute ...................................................................... 29
             Aphios Enters Into Research And Co-Development Agreement With VivaCell Biotech ............................................................ 30
          Licensing Agreements .................................................................................................................................................................. 31
             Aphios Enters Into A Licensing Agreement With LSUHSC Shreveport ..................................................................................... 31
       Aphios Corporation - Key Competitors ............................................................................................................................................. 32
       Key Employees ................................................................................................................................................................................ 33
       Locations And Subsidiaries .............................................................................................................................................................. 34
          Head Office ................................................................................................................................................................................... 34
       Recent Developments ...................................................................................................................................................................... 35
          Product News ............................................................................................................................................................................... 35
             Jan 24, 2012: Aphios Receives Phase II SBIR Grant From National Institute On Aging For Alzheimer's Disease Research ... 35
       Appendix .......................................................................................................................................................................................... 36
          Methodology ................................................................................................................................................................................. 36
          About GlobalData ......................................................................................................................................................................... 36
          Contact Us .................................................................................................................................................................................... 36
          Disclaimer ..................................................................................................................................................................................... 36




Aphios Corporation - Pharmaceuticals & Healthcare - Deals and                                                                                                      Reference Code: GDPH26177D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       List of Tables
       Aphios Corporation, Pharmaceuticals & Healthcare, Key Facts ......................................................................................................... 1
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................... 1
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................... 1
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ..................................................... 1
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................... 4
       Aphios Corporation, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................................... 5
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................... 6
       Aphios Corporation, Deals By Therapy Area, 2007 to YTD 2013 ....................................................................................................... 7
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ................................................................ 8
       Aphios Enters Into An Agreement With SAIC-Frederick ..................................................................................................................... 9
       Aphios Enters Into Co-Development Agreement With National Cancer Institute.............................................................................. 29
       Aphios Enters Into Research And Co-Development Agreement With VivaCell Biotech ................................................................... 30
       Aphios Enters Into A Licensing Agreement With LSUHSC Shreveport ............................................................................................ 31
       Aphios Corporation, Key Competitors .............................................................................................................................................. 32
       Aphios Corporation, Key Employees ................................................................................................................................................ 33


       List of Figures
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 ................................................................... 1
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................... 4
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 ................................................................... 5
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................... 6
       Aphios Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ..................................................... 7




Aphios Corporation - Pharmaceuticals & Healthcare - Deals and                      
				
DOCUMENT INFO
Description: Aphios Corporation (Aphios) is a pharmaceutical company. The company develops technology platforms and enhanced therapeutics for the treatment of certain infectious diseases, cancers and CNS disorders. Its product pipeline includes Zindol, an enhanced ginger product; APH-0703, a potent protein kinase C activator; APH-0812, a combination therapy consisting of PKC modulators with or without HDAC inhibitors; AMPI-109, a nontoxic Vitamin D3 derivative for hormone refractory prostate cancer; APH-0911, a nanotechnology formulation; and others. The company offers biotechnology and nanotechnology drug delivery platforms. It provides therapeutic products for disease prevention, cancers, infectious diseases, central nervous system disorders, HIV-AIDS therapeutic vaccine, anti-influenza, and vaccine adjuvant technology. Aphios is headquartered in Woburn, Massachusetts, the US. Aphios Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the numbe
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.